3.49
-0.15(-4.12%)
Currency In USD
| Previous Close | 3.64 |
| Open | 3.54 |
| Day High | 3.6 |
| Day Low | 3.46 |
| 52-Week High | 21.98 |
| 52-Week Low | 3.1 |
| Volume | 244,507 |
| Average Volume | 857,727 |
| Market Cap | 63.91M |
| PE | -0.65 |
| EPS | -5.37 |
| Moving Average 50 Days | 4.28 |
| Moving Average 200 Days | 11.78 |
| Change | -0.15 |
If you invested $1000 in Outset Medical, Inc. (OM) since IPO date, it would be worth $3.83 as of February 28, 2026 at a share price of $3.49. Whereas If you bought $1000 worth of Outset Medical, Inc. (OM) shares 4 years ago, it would be worth $4.56 as of February 28, 2026 at a share price of $3.49.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned
GlobeNewswire Inc.
Jan 27, 2026 2:00 PM GMT
Tablo becomes first dialysis system to clear FDA’s most rigorous cybersecurity standardsSAN JOSE, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to
Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026
GlobeNewswire Inc.
Jan 26, 2026 9:05 PM GMT
SAN JOSE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will rel
Outset Medical Reports Unaudited Fourth Quarter and 2025 Results
GlobeNewswire Inc.
Jan 12, 2026 1:30 PM GMT
Appoints Medical Technology Veteran Karen N. Prange to Board of DirectorsSAN JOSE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and co